AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2022
Jan 4, 2022
33153_dirs_2022-01-04_2b8ab2ad-df2b-48fe-a8d0-9f5245c1cae5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2022-01-03
Reporting Person: Schmieder John Bradley (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-03 | Common Stock | M | 1000 | $97.78 | Acquired | 72015 | Direct |
| 2022-01-03 | Common Stock | S | 1000 | $327.77 | Disposed | 71015 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | Non Qualified Stock Option | $97.78 | X | 1000 | Disposed | 2022-04-01 | Common Stock (1000) | Direct |
Footnotes
F1: 1/5 exercisable on each anniversary date of the 04/01/2016 grant date
F2: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2021
More from MESA LABORATORIES INC /CO/
Share Issue/Capital Change
2026
Jun 3
Annual Report
2026
Jun 2
Report Publication Announcement
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3